MustGrow Biologics Corp. (MGRO.V)
- Previous Close
1.1000 - Open
1.0900 - Bid 1.0000 x --
- Ask 1.2000 x --
- Day's Range
0.7600 - 1.1500 - 52 Week Range
0.7200 - 2.5400 - Volume
126,703 - Avg. Volume
21,407 - Market Cap (intraday)
51.6M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 26, 2024 - May 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MustGrow Biologics Corp., an agricultural biotech company, focuses on development and commercialization of natural biopesticides, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops; and TerraMG, a mustard-derived soil biopesticide technology for use as a preplant soil biopesticide for soil-borne diseases and pests for various crops, such as fruits & vegetables, bananas, canola, and pulses. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.
mustgrow.ca--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MGRO.V
Performance Overview: MGRO.V
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MGRO.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MGRO.V
Valuation Measures
Market Cap
51.60M
Enterprise Value
45.54M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.59
Price/Book (mrq)
9.24
Enterprise Value/Revenue
9.66
Enterprise Value/EBITDA
-67.28
Financial Highlights
Profitability and Income Statement
Profit Margin
-14.37%
Return on Assets (ttm)
-1.87%
Return on Equity (ttm)
-12.51%
Revenue (ttm)
4.71M
Net Income Avi to Common (ttm)
-676.94k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
6.82M
Total Debt/Equity (mrq)
13.60%
Levered Free Cash Flow (ttm)
694.61k
Company Insights: MGRO.V
MGRO.V does not have Company Insights